Trondheim, Norway

Helga Ertesvag

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fmc Biopolymer as. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helga Ertesvag. Retrieved from https://idiyas.com/inventor/helga-ertesvag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helga Ertesvag: Innovator in Alginate Production

Introduction

Helga Ertesvag is a notable inventor based in Trondheim, Norway. She has made significant contributions to the field of biotechnology, particularly in the production of alginate through innovative methods involving bacterial cultures.

Latest Patents

Helga holds 1 patent that describes biologically pure bacterial cultures of mutant strains which produce large amounts of alginate. The patent details the alginate's composition, including specific contents of mannuronate and guluronate residues, as well as the presence and determined level of acetyl groups. Additionally, it outlines methods for producing new mutant strains and variants, emphasizing the regulation of alginate production.

Career Highlights

Throughout her career, Helga has worked with prominent companies such as Fmc Biopolymer AS and Algipharma AS. Her work has focused on enhancing alginate production, which has applications in various industries, including food and pharmaceuticals.

Collaborations

Helga has collaborated with notable colleagues, including Martin Gimmestad and Havard Sletta, contributing to advancements in her field.

Conclusion

Helga Ertesvag's innovative work in alginate production showcases her expertise and dedication to biotechnology. Her contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…